|
 |
VisicolThis page contains recent news articles, when available, and an overview of Visicol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.On December 11, 2008, the FDA required new warnings for OsmoPrep and Visicol, another prescription oral sodium phosphate product. The “black boxâ€? warning, ... AboutLawsuits.com Suits Commenced Against Maker of Prescription Cleansing Drug - Dec 23, 2009 Salix also sells a product, Visicol, with similar chemicals and has the same purpose. In December 2008, after receiving a number of reports of kidney injury ... CNNMoney.com (press release) Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of ... - Dec 10, 2009 For full prescribing information and important safety information, including BOXED WARNINGS for VISICOL, OSMOPREP and METOZOLV, on Salix products, ... PharmaLive.com (press release) Salix Pharmaceuticals to Present at Credit Suisse Conference - Nov 4, 2009 For full prescribing information, including BOXED WARNINGS for VISICOL, OSMOPREP and METOZOLV, on Salix products, please visit www.salix.com or contact the ... Reuters Salix Pharmaceuticals Reports 3Q2009 Results - Nov 9, 2009 For full prescribing information and important safety information, including BOXED WARNINGS for VISICOL, OSMOPREP and METOZOLV, on Salix products, ... WELT ONLINE Salix Pharmaceuticals Reviews American Association for the Study of Liver ... - Nov 2, 2009 For full prescribing information, including BOXED WARNINGS for VISICOL, OSMOPREP and METOZOLV, on Salix products, including BOXED WARNINGS for OSMOPREP, ... WELT ONLINE Salix Beats on Xifaxan Strength - Nov 11, 2009 The bowel cleansing franchise, consisting of MoviPrep, Visicol and OsmoPrep generated revenue of $16.6 million in the third quarter of 2009, ... Zacks.com Salix Pharmaceuticals Previews American College of Gastroenterology 2009 ... - Oct 26, 2009 Salix also markets OSMOPREP® (sodium phosphate monobasic monohydrate, USP and sodium phosphate dibasic anhydrous, USP) Tablets, VISICOL® (sodium phosphate ... Reuters Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to ... - Nov 3, 2009 For full prescribing information, including BOXED WARNINGS for VISICOL, OSMOPREP and METOZOLV, on Salix products, please visit www.salix.com or contact the ... Reuters Salix Pharmaceuticals, Ltd. - Pharmaceuticals & Healthcare - Deals and ... - Nov 13, 2009 As of December 31, 2008, the Company's products were XIFAXAN (rifaximin) Tablets 200 milligram; MOVIPREP; OSMOPREP, VISICOL Tablets, AZASAN Azathioprine ... PR-inside.com (press release) Salix Pharmaceuticals drugs to get black-box warning; shares slump - Dec 11, 2008 The Food and Drug Administration said the Salix drugs Visicol and OsmoPrep, ... Both Visicol and OsmoPrep are in the family of products known as oral sodium ... Bizjournals.com Danger to Kidneys May Lurk in Some Preparations for Colonoscopies - Dec 27, 2005 The products are oral preparations made with sodium phosphate and they include Visicol tablets, sold by prescription, and over-the-counter solutions like ... New York Times Colonoscopy prep pills carry kidney risk - Dec 16, 2008 The FDA says prescription Visicol, approved in 2000, and its successor, OsmoPrep, approved in 2006, should be used with caution by people over 55; ... Pay-Per-View - USA TODAY - ProQuest Archiver InKine Announces Positive Phase 3 Study Results of Next Generation … - Feb 22, 2005 For the comparison of each INKP-102 regimen to Visicol(R), ... Both of the INKP-102 doses were statistically superior to Visicol(R) in terms of the amount ... Free with registration - Business Wire - AccessMyLibrary.com InKine to close office in Montco - The pharmaceuticals firm employs... - Jun 25, 2005 Visicol is the only tablet approved by the Food and Drug Administration for bowel preparation before ... Visicol sales were about $21 million last year. ... $2.95 - Philadelphia Inquirer - NewsBank Non-liquid colonoscopy prep approved, Pills ease process, but some … - Apr 25, 2006 Last year Salix Pharmaceuticals bought out Inkine Pharmaceuticals, which has produced a bowel cleansing prescription tablet, known as Visicol, for six years ... Pay-Per-View - Newsday - ProQuest Archiver Salix Pharmaceuticals Reports American College of Gastroenterology … - Jul 10, 2008 VISICOL (87%), 3) would take same preparation in future: INKP-102 (95%) vs. VISICOL (88%) and 4) would repeat colonoscopy if the preparation is available ... businesswire.com Salix drug gets approval - Mar 18, 2006 Unlike Visicol, OsmoPrep leaves no residue in the colon. ... One patient had taken Visicol, Salix's prescription sodium phosphate pill. ... News & Observer Gastroenterology; Positive results reported from INKP-102 study in … - Mar 25, 2005 Both of the INKP-102 arms utilized a dosing schedule that was of shorter duration, more convenient, and less complicated than the Visicol dosing regimen. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Salix grows revenue, but profit shrinks on R&D costs - May 8, 2007 Colazal and travelers' diarrhea drug Xifaxan, jumped, as did sales of the company's bowel-cleansing drug line - Moviprep, Osmoprep and Visicol. ... Triangle Business Journal Event Brief of Q2 2007 Salix Pharmaceuticals, Inc. Earnings Conference... - Aug 2, 2007 MOVIPREP, OSMOPREP, VISICOL, which comprise of bowel cleansing product line, generated revenue of $11.4m for 2Q07 vs. $17.5m for 2Q06. 1. ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Salix Pharmaceuticals Reports Digestive Disease Week 2006 Update; … - May 23, 2006 VISICOL(R) Tablets are the only FDA approved tablets available to adults for bowel ... VISICOL Tablets are virtually taste-free, can be taken with any clear ... RedOrbit InKine gets $1M payment from Zeria - Mar 29, 2005 The ALW Partnership, the owners of the Visicol patent, will receive a $300000 payment from InKine as a result of the Zeria milestone payment, ... Philadelphia Business Journal InKine Announces Submission of a New Drug Application -NDA- for Its … - May 3, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext Salix buying InKine in $190M deal - Jun 23, 2005 Blue Bell, Pennsylvania-based InKine sells Visicol, a tablet that cleanses the bowels ... Visicol had a little more than $20 million in revenue last year. ... FierceBiotech InKine's Visicol Tablets Associated with Significantly Less After... - May 19, 2005 BLUE BELL, Pa. -- InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced that Michael D. Brown, MD, Associate Professor of Medicine, ... $4.95 - Business Wire - ECNext Salix Pharmaceuticals Reports American College of Gastroenterology … - Oct 23, 2006 XIFAXAN([R]), COLAZAL([R]), OSMOPREP[TM], VISICOL([R]) and MOVIPREP([R] )Sunday, October 22 Poster Presentation Highlights. $4.95 - Business Wire - ECNext Press Release: InKine's visicol tablets associated with significantly... - May 20, 2005 InKine's visicol tablets associated with significantly less after-hours calls to physicians than liquid purgatives, ViroPharma to present at the fourth ... Pay-Per-View - M2 Presswire - HighBeam Research Salix Pharmaceuticals Completes Merger with InKine Pharmaceutical; … - Jul 10, 2008 The addition of the existing and growing revenue from VISICOL(R), ... VISICOL Tablets are the only FDA-approved tablets available to adults for bowel ... businesswire.com InKine's visicol tablets associated with significantly less after... - May 20, 2005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) announced ... $4.95 - M2 Presswire - ECNext Gastroenterology; Positive results reported from INKP-102 study in … - Mar 21, 2005 Both of the INKP-102 arms utilized a dosing schedule that was of shorter duration, more convenient, and less complicated than the Visicol dosing regimen. ... Pay-Per-View - Gastroenterology Week - Factiva, from Dow Jones Salix Pharmaceuticals Reports American College of Gastroenterology … - Oct 24, 2006 No serious adverse events related to VISICOL were observed. Two patients treated with VISICOL discontinued treatment after 5-6 months. About Salix ... Free with registration - Business Wire - AccessMyLibrary.com InKine Reports Seven INKP-102 Study Data Abstracts Accepted for … - Aug 3, 2005 These trials indicate that INKP-102 may have important advantages over Visicol(R) tablets in efficacy, safety, and acceptance by patients. Visicol(R) is the ... $4.95 - Business Wire - ECNext Salix Pharmaceuticals Announces Imminent Launch of Visiclear(R) in … - Jun 8, 2007 VISICOL([R]) Tablets are indicated for cleansing of the bowel as a ... VISICOL Tablets are virtually taste-free, can be taken with any clear liquid such as ... Free with registration - Business Wire - AccessMyLibrary.com BOWEL-CLEANSING-DRUG MAKERS GIVE THEIR SIDE OF THE … - Mar 29, 2006 The makers of Visicol, a bowel-cleansing drug used in colonoscopies, ... "Visicol, which accounts for approximately 15 percent of the number of ... Pay-Per-View - Palm Beach Post - Factiva, from Dow Jones Salix Pharmaceuticals Reports American College of Gastroenterology … - Oct 24, 2006 XIFAXAN([R]), COLAZAL([R]), OSMOPREP[TM], VISICOL([R]) and MOVIPREP([R]) RALEIGH, NC -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today reported on results ... $4.95 - Business Wire - ECNext Salix Pharmaceuticals Announces Imminent Launch of Visiclear(R) in … - Jun 8, 2007 VISICOL([R]) Tablets are indicated for cleansing of the bowel as a ... VISICOL Tablets are virtually taste-free, can be taken with any clear liquid such as ... $4.95 - Business Wire - ECNext Salix Pharmaceuticals Announces American College of Gastroenterology ... - Oct 16, 2006 XIFAXAN(R), COLAZAL(R), OSMOPREP(TM), VISICOL(R) and MOVIPREP(R) Studied in Investigator-Initiated and Company-Sponsored Trials. $4.95 - Business Wire - ECNext Salix Pharmaceuticals Completes Merger with InKine Pharmaceutical; … - Oct 3, 2005 The addition of the existing and growing revenue from VISICOL(R), ... VISICOL Tablets are the only FDA-approved tablets available to adults for bowel ... $4.95 - Business Wire - ECNext Salix Pharmaceuticals Reports American College of Gastroenterology … - Oct 23, 2006 VISICOL([R])Tablets are the only FDA approved tablets available to adults ... VISICOL Tablets are virtually taste-free, can be taken with any clear liquid ... Free with registration - Business Wire - AccessMyLibrary.com EDITED BRIEF - May 6, 2008 MOVIPREP, OSMOPREP and VISICOL, which comprise bowel cleansing product line, ... one-time VISICOL product return due to product expiration. ... $54.00 - Thomson StreetEvents - Alacra Store Salix Pharmaceuticals Reports American College of Gastroenterology … - Oct 23, 2006 XIFAXAN([R]), COLAZAL([R]), OSMOPREP[TM], VISICOL([R]) and MOVIPREP([R]) RALEIGH, NC -- Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today reported on results ... $4.95 - Business Wire - ECNext How to safely prepare for a colonoscopy - Dec 22, 2008 This is found not only in OsmoPrep and Visicol, but also in some over-the-counter drugs that are meant to be taken as laxatives but are taken in high doses ... Los Angeles Times InKine Reports Second Quarter 2005 Financial Results. - Aug 8, 2005 Approximately 145000 prescriptions were filled for Visicol(R) during the second quarter of 2005, which represents an increase of approximately 23% over ... $4.95 - Business Wire - ECNext Sodium phosphate bowel prep approved - Apr 17, 2006 OsmoPrep had a more favorable side-effect profile than Visicol, with lower rates of nausea, vomiting, and abdominal bloating and pain. ... Medscape Salix Pharmaceuticals Reports 1Q2006 Results - Mar 31, 2006 VISICOL(R) generated revenue of $9.8 million for the first quarter of 2006, ... At the end of the first quarter of 2006, VISICOL inventories were ... businesswire.com InKine Announces the Acceptance for Filing of Its New Drug Application... - Jul 26, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext With positive drug results, InKine preparing NDA.(new drug application... - Feb 28, 2005 Visicol in three groups of patients who underwent colonoscopy. ... The third group received the FDA-approved dose of 40 Visicol tablets. ... Pay-Per-View - BioWorld Week - Factiva, from Dow Jones Pet prescription for health? ; While medical benefits are unproven,... - Feb 17, 2006 The patient takes 28 to 32 pills of Visicol, but this carries the same risks as the ... In very rare instances, a tablet called Visicol has been linked with ... Pay-Per-View - The Sun - ProQuest Archiver Article: Bowel-cleansing and nephropathy. - Internal Medicine News | ... - Jun 15, 2006 Warning to the prescription oral sodium phosphate products Visicol and OsmoPrep . ... These products include prescription drugs Visicol ... ... Pay-Per-View - Internal Medicine News - HighBeam Research Salix Pharmaceuticals Reports 1Q2007 Results - Mar 31, 2007 MOVIPREP, OSMOPREP and VISICOL at quarter end commanded an impressive 23% share of the prescription bowel cleansing market and we anticipate our share of ... businesswire.com Colonoscopy; Enrollment completed for INKP-102 phase III colonoscopy ... - Jan 10, 2005 INKP-102 tablets are smaller than Visicol tablets and contain no microcrystalline cellulose, an inert but highly insoluble substance in Visicol tablets. ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Colonoscopy; Enrollment completed for INKP-102 phase III colonoscopy ... - Jan 7, 2005 INKP-102 tablets are smaller than Visicol tablets and contain no microcrystalline cellulose, an inert but highly insoluble substance in Visicol tablets. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Colonoscopy; Enrollment completed for INKP-102 phase III colonoscopy ... - Jan 4, 2005 INKP-102 tablets are smaller than Visicol tablets and contain no microcrystalline cellulose, an inert but highly insoluble substance in Visicol tablets. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Salix Pharmaceuticals Reports 1Q2006 Results - May 4, 2006 VISICOL(R) generated revenue of $9.8 million for the first quarter of 2006, compared to $5.2 million a year ago when InKine was independent. ... Genetic Engineering News - Genetic Engineering News (press release) Article: Refrigerated FluMist wins approval; cost still an issue.(News... - Feb 1, 2007 InKine ... presented to demonstrate that the new formulation of Visicol was safe and effective ... supplement, which demonstrated that the new formulation ... Pay-Per-View - Family Practice News - HighBeam Research Caution urged with bowel purgatives in elderly - Nov 6, 2005 While further investigation is needed, Markowitz believes that based on these results, physicians prescribing OSPS or Visicol should exercise extreme ... Medscape Press Release: Stocks on the Rise- LDPH, AVNR, FGBF. - M2 Presswire |... - Jun 1, 2007 InKine ... presented to demonstrate that the new formulation of Visicol was safe and effective ... supplement, which demonstrated that the new formulation ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Uses for speech are becoming diversified as the voice ... - Mar 31, 2008 ASGE) cite sodium phosphate tablets (Visicol) as 1 of 3 widely accepted bowel ... The guidelines appear ... guidelines developed by ASGE cites Visicol ... Pay-Per-View - M2 Presswire - HighBeam Research Article: Oral purgatives linked with acute kidney injury.(News) -... - Dec 1, 2007 Administration has added a boxed warning to the prescription oral sodium phosphate bowel preparation products Visicol and OsmoPrep ... recommending ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: DOW inaugurates new formulation lab in Spain.(Industry News)... - Jun 1, 2008 InKine ... presented to demonstrate that the new formulation of Visicol was safe and effective ... supplement, which demonstrated that the new formulation ... Pay-Per-View - Coatings World - HighBeam Research InKine CEO To Open Nasdaq Stock Market In Honor Of Colorectal Cancer … - Mar 18, 2005 InKine is the manufacturer of Visicol(R) tablets, the first and only FDA ... We believe that Visicol(R) and our next generation purgative, INKP-102, ... $4.95 - Business Wire - ECNext InKine pulls plug on experimental Crohn's disease drug - Jan 14, 2005 Visicol is already in the market for colon cleansing in patients undergoing colonoscopies. Results of a phase-II clinical study of INKP-102, ... Bizjournals.com Business News in Brief - May 4, 2005 Visicol is an FDA-approved tablet to cleanse the colon before colonoscopy. InKine reduced its expected 2005 revenue range to $23 million to $27 million from ... $2.95 - Philadelphia Inquirer - NewsBank Business News in Brief - Jun 24, 2005 However, the company lowered its 2005 full-year earnings and revenue forecasts because it expected slower growth in Visicol prescriptions due to increased ... $2.95 - Philadelphia Inquirer - NewsBank Article: MIXOLOGY 101 - The Record (Bergen County, NJ) | HighBeam … - Sep 17, 2008 Article: InKine Confirms Effect of Ginger Ale On Visicol ... Business Wire; November 5, 2001 ; 700+ words ... ... demonstrated the beneficial effects of ... Pay-Per-View - The Record - HighBeam Research 2 asthma inhalers likely to be pulled - Dec 11, 2008 The new warning label will apply to Visicol and OsmoPrep -- both prescription tablets made by Salix Pharmaceuticals. The label says the drugs should be used ... Minneapolis Star-Tribune - Minneapolis Star Tribune Q3 2006 Salix Pharmaceuticals, Inc. Earnings Conference Call - Final. - Nov 7, 2006 Our bowel cleansing franchise which in the third quarter was comprised of three marketed products, VISICOL and the newly approved and launched OsmoPrep and ... Free with registration - Fair Disclosure Wire - AccessMyLibrary.com Q4 2005 SALIX PHARMACEUTICALS INC Earnings Conference Call - … - Feb 24, 2006 We acquired three products with long-term patent protection, Visicol, INKP-102, and NRL944, and expanded our sales force by more than 40% during the year. ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Bowel Preps The Current and Future Outlook - Jun 1, 2005 These new INKP-102 tablets are designed to be smaller in size and easier to swallow than InKine's Visicol® tablets, and contain no microcrystalline ... EndoNurse InKine Announces Conference Call for Fourth Quarter and Year End … - Feb 16, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... Free with registration - Business Wire - AccessMyLibrary.com Inkine Announces Date Change to February 23rd for Earnings Results … - Feb 18, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... Free with registration - Business Wire - AccessMyLibrary.com å?£æœ?磷酸鹽產å“?與急性磷腎病變有關 - Dec 12, 2008 ...除了Visicol與OsmoPrep之外，這經常使用於清腸ã€?或å?šç‚ºå¤§è…¸é?¡ä»¥å?Šå…¶ä»–檢查準備用，OSP 產å“?包括é?žè™•æ–¹ç·©ç€‰åŠ‘，例如Fleet Phospho-soda（CB Fleetå…¬å?¸ï¼‰ã€‚ ... udn.com Suits allege laxative caused kidney failure - Aug 15, 2007 The alert, which cautioned doctors to carefully choose bowel cleansers, named Phospho-soda and Visicol tablets as examples of such medications, ... Minneapolis Star-Tribune - Minneapolis Star Tribune InKine Announces Final Court Approval in Securities Class Action … - Jun 16, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext InKine CEO To Present at the Rodman & Renshaw Techvest 2nd Annual … - Apr 28, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext InKine CEO to Present at the UBS Global Pharmaceuticals Conference. - May 17, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext InKine CEO To Present at White Mountain Capital's Third Annual … - Apr 13, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext San Francisco to lay off 400 city workers - Dec 12, 2008 The warning label will apply to Visicol and OsmoPrep — prescription tablets from Salix Pharmaceuticals. The label warns that the drugs should be used with ... USA Today A safer colon cleansing?(Cover story) - Jul 24, 2006 Visicol (sodium phosphate, dibasic, anhydrous, sodium phosphate, monobasic, monohydrate) tablets, by Salix Pharmaceuticals, was the product used by one of ... $4.95 - Drug Topics - ECNext Nation's Leading Independent Proxy Advisory Firm Recommends That … - Sep 20, 2005 InKine's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. InKine's second product ... $4.95 - Business Wire - ECNext Article: Hydrotherapy may offer bowel prep advantages.(Gastroenterolog... - Dec 1, 2006 Endoscopy (ASGE) cite sodium phosphate tablets (Visicol ... based preparation, sodium phosphate tablets demonstrated ... guidelines stated that "sodium ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: Gov't Targets Atheist's Inauguration Suit - AP Online |... - Jan 10, 2005 ASGE) cite sodium phosphate tablets (Visicol) as 1 of 3 widely accepted bowel ... The guidelines appear ... guidelines developed by ASGE cites Visicol ... Pay-Per-View - AP Online - HighBeam Research Article: New formulation of phenytoin.(PRODUCTS) - Internal Medicine ... - Dec 1, 2006 InKine ... presented to demonstrate that the new formulation of Visicol was safe and effective ... supplement, which demonstrated that the new formulation ... Pay-Per-View - Internal Medicine News - HighBeam Research Press Release: Research and Markets: The Essential Specialty … - Mar 11, 2005 Marketing for InKine stated "The new trade name, Visicol(TM), derived from visi ... the statement regarding that the new trade name Visicol(TM) provides ... Pay-Per-View - PR Newswire - HighBeam Research InKine Appoints John M. Cullen, Ph.D., JD to Senior Vice President... - Jan 31, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext Article: Hydrotherapy excels as safe, tolerable bowel prep.(Digestive... - Dec 1, 2006 Visicol tablets (sodium phosphate) are available for bowel cleansing prior to colonoscopy. This is the first bowel purgative preparation available in a ... Pay-Per-View - Family Practice News - HighBeam Research Salix Pharmaceuticals Reports 2Q2006 Results. - Aug 8, 2006 Our bowel cleansing franchise, which in the second quarter was comprised of two marketed products, VISICOL(R) and the newly-approved OSMOPREP(TM), ... $4.95 - Business Wire - ECNext Press Release: Research and Markets: A Comprehensive and Helpful … - Mar 11, 2005 Marketing for InKine stated "The new trade name, Visicol(TM), derived from visi ... the statement regarding that the new trade name Visicol(TM) provides ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Research and Markets: Vital Read for Those in Textiles... - Mar 11, 2005 Marketing for InKine stated "The new trade name, Visicol(TM), derived from visi ... the statement regarding that the new trade name Visicol(TM) provides ... Pay-Per-View - PR Newswire - HighBeam Research themself | Definition of themself | HighBeam.com: Online Dictionary - Jul 12, 2006 ASGE) cite sodium phosphate tablets (Visicol) as 1 of 3 widely accepted bowel ... The guidelines appear ... guidelines developed by ASGE cites Visicol ... Pay-Per-View - Oxford American College Dictionary - HighBeam Research InKine Announces Conference Call for First Quarter Financial Results. - Apr 27, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext Colon Cancer Alliance Appoints InKine CEO, Leonard S. Jacob, MD, Ph. … - Jan 18, 2005 The Company's franchise product, Visicol(R) is the only tablet purgative preparation indicated for bowel cleansing prior to colonoscopy. ... $4.95 - Business Wire - ECNext Article: Gelatin turns hip, healthy with less refined sugar - The... - Nov 1, 2006 Article: InKine Confirms Effect of Ginger Ale On Visicol ... Business Wire; November 5, 2001 ; 700+ words ... ... demonstrated the beneficial effects of ... Pay-Per-View - The Record - HighBeam Research Salix touts colon-cancer prevention. - Feb 28, 2007 Salix markets three of them -- OsmoPrep, MoviPrep and Visicol. Staff writer Sabine Vollmer can be reached at (919) 829-8992 or svollmer@newsobserver.com. Free with registration - News & Observer - AccessMyLibrary.com UPI NewsTrack Health and Science News - Dec 11, 2008 11 (UPI) -- The US Food and Drug Administration says it will add a "Boxed Warning" to prescription oral sodium phosphate products Visicol and OsmoPrep. ... United Press International Salix scores French licensing deal - Oct 4, 2007 Revenue from the company's line of purgatives, including Osmoprep as well as the drugs MoviPrep and Visicol, have increased in recent quarters. ... Bizjournals.com New Smoking Bans, Allergies and Pregnancy, and Colonoscopy Drugs … - Dec 12, 2008 The oral phosphates Visicol and OsmoPrep should be used with caution by the elderly and anyone suffering kidney problems. New York Times US FDA warns of kidney damage in bowel cleansers - Dec 11, 2008 It said it would require the warnings of Salix Pharmaceuticals Ltd (nasdaq: SLXP - news - people )'s Visicol and OsmoPrep products to caution about the risk ... Forbes FDA Puts Black Box Warning on Bowel-Cleansing Drugs - Dec 10, 2008 The FDA said it would now require a black-box warning on the oral sodium phosphate products Visicol and OsmoPrep, alerting consumers about the risk of acute ... Forbes Bowel Cleansers Get FDA Warning - May 5, 2006 One patient had taken Visicol tablets. None had taken OsmoPrep tablets, a recently approved oral sodium phosphate product, the FDA said. San Francisco Chronicle WASHINGTON IN BRIEF - May 6, 2006 One patient had taken Visicol tablets. None had taken OsmoPrep tablets, a recently approved oral sodium phosphate product, the FDA said. ... Pay-Per-View - Washington Post - ProQuest Archiver Atlanta health, diet and fitness news | ajc.com - Mar 7, 2006 Common bowel-cleansing drugs that contain sodium phosphate include the prescription oral tablet Visicol and the non-prescription product Fleet Phospho-soda, ... Atlanta Journal Constitution I will always keep this health promise - Mar 9, 2007 And so the last time I had a colonoscopy, I used the so-called "pill prep" (trade name Visicol). Some readers wrote and said their doctors believe that this ... $3.50 - The Gazette - NewsBank Are there risks to colonoscopy prep procedures? - Feb 6, 2006 ...there is a pill-only prep. The patient takes 28 to 32 pills of Visicol, but this carries the some risks and may not yield a clean enough colon. Boston Globe Article: Healthy living is a mug's game; You have a stinking cold,... - Feb 20, 2005 Article: InKine Confirms Effect of Ginger Ale On Visicol ... Business Wire; November 5, 2001 ; 700+ words ... ... demonstrated the beneficial effects of ... Pay-Per-View - Sunday Mercury - HighBeam Research Article: Cocktail Of The Week; ST GEORGE'S DAY COCKTAIL.(Features) - … - Apr 24, 2008 Article: InKine Confirms Effect of Ginger Ale On Visicol ... Business Wire; November 5, 2001 ; 700+ words ... ... demonstrated the beneficial effects of ... Pay-Per-View - Birmingham Mail - HighBeam Research Article: Eminem in Slane demand.(News) - The Mirror (London, England)... - Jun 8, 2005 Article: InKine Confirms Effect of Ginger Ale On Visicol ... Business Wire; November 5, 2001 ; 700+ words ... ... demonstrated the beneficial effects of ... Pay-Per-View - The Mirror - HighBeam Research WASHINGTON IN BRIEF | Article from The Washington Post | HighBeam … - May 6, 2006 One patient had taken Visicol tablets. None had taken OsmoPrep tablets, a recently approved oral sodium phosphate product, the FDA said. ... Pay-Per-View - Washington Post - HighBeam Research InKine and Salix ito merge - Sep 30, 2005 InKine's franchise product, Visicol, is the only tablet purgative preparation approved by the Food and Drug Administration for bowel cleansing prior to ... Bizjournals.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |